Zhu Jun, Wan Shuisen, Zhao Xueqi, Zhu Binlu, Lv Yuan, Jiang Hongkun
Department of Pediatrics, The First Hospital of China Medical University, Shenyang, China.
Department of Pediatrics, West China Second University Hospital, Chengdu, China.
Front Genet. 2022 Apr 14;13:856552. doi: 10.3389/fgene.2022.856552. eCollection 2022.
Methylmalonic acidemia (MMA) can display many clinical manifestations, among which acute lymphoblastic leukemia (ALL) has not been reported, and congenital heart disease (CHD) is also rare. We report an MMA case with ALL and CHD in a 5.5-year-old girl. With developmental delay and local brain atrophy in MRI, she was diagnosed with cerebral palsy at 9 months old. Rehabilitation was performed since then. This time she was admitted to hospital because of weakness and widespread bleeding spots. ALL-L2 (pre-B-cell) was confirmed by bone marrow morphology and immunophenotyping. Echocardiography showed patent foramen ovale. The girl was treated with VDLD and CAML chemotherapy, during which she developed seizures, edema and renal insufficiency. Decrease of muscle strength was also found in physical examination. Screening for inherited metabolic disorders showed significantly elevated levels of methylmalonate-2, acetylcarnitine (C2), propionylcarnitine (C3), C3/C2 and homocysteine. Gene analysis revealed a compound heterozygous mutaion in (NM_015,560): c.80A > G (p.Gln27Arg) and c.609G > A (p.Trp203*). CblC type MMA was diagnosed. Intramuscular injection of cyanocobalamin and intravenous L-carnitine treatment were applied. The edema vanished gradually, and chemotherapy of small dosage of vindesine was given intermittently when condition permitted. 2 months later, muscle strength of both lower limbs were significantly improved to nearly grade 5. The levels of methylmalonic acid and homocysteine were improved. Metabolic disease screening and gene analysis are very necessary for diseases with complex clinical symptoms. ALL can be a rare manifestation for MMA. We report a case of methylmalonic acidemia with acute lymphoblastic leukemia and congenital heart disease, which uncovered the importance of genetic testing and metabolic diseases screening in patients with multiple systemic organ involvement.
甲基丙二酸血症(MMA)可表现出多种临床表现,其中急性淋巴细胞白血病(ALL)尚未见报道,先天性心脏病(CHD)也较为罕见。我们报告一例5.5岁患ALL和CHD的女童MMA病例。她9个月大时因发育迟缓及MRI显示局部脑萎缩被诊断为脑瘫,此后一直进行康复治疗。此次因乏力和广泛出血点入院。骨髓形态学和免疫表型分析确诊为ALL-L2(前B细胞型)。超声心动图显示卵圆孔未闭。该女童接受VDLD和CAML化疗,期间出现癫痫发作、水肿和肾功能不全。体格检查还发现肌力下降。遗传性代谢疾病筛查显示甲基丙二酸-2、乙酰肉碱(C2)、丙酰肉碱(C3)、C3/C2和同型半胱氨酸水平显著升高。基因分析显示(NM_015,560)存在复合杂合突变:c.80A > G(p.Gln27Arg)和c.609G > A(p.Trp203*)。诊断为CblC型MMA。给予肌肉注射氰钴胺和静脉注射L-肉碱治疗。水肿逐渐消退,病情允许时间歇性给予小剂量长春地辛化疗。2个月后,双下肢肌力显著改善至近5级。甲基丙二酸和同型半胱氨酸水平有所改善。对于临床症状复杂的疾病,代谢疾病筛查和基因分析非常必要。ALL可能是MMA的一种罕见表现。我们报告一例合并急性淋巴细胞白血病和先天性心脏病的甲基丙二酸血症病例,揭示了基因检测和代谢疾病筛查在多系统器官受累患者中的重要性。